文献速递腹部CT

对比增强双源双能量CT上虚拟平扫CT检测中度肝脂肪变性的作用与准确性

Detection of moderate hepatic steatosis on contrast-enhanced dual-source dual-energy CT: Role and accuracy of virtual non-contrast CT.
PubMed 文献 · Eur J Radiol · 2024-01-30

本单机构回顾性研究纳入多期相双源双能量CT检查患者,以真平扫肝脏衰减<40 HU定义至少中度肝脂肪变性,评估虚拟平扫CT的诊断准确性并确定新阈值。虚拟平扫CT全肝AUC为0.92,阈值40 HU时敏感度100%、特异度42%,优化阈值46 HU时敏感度69%、特异度95%,验证队列表现相似。作者认为虚拟平扫CT有较好应用前景,46 HU阈值提供高特异度和中等敏感度。

要点

  • 虚拟平扫CT全肝检测至少中度肝脂肪变性的AUC为0.92(95%CI 0.86-0.98)。
  • 阈值40 HU时敏感度100%、特异度42%;优化阈值46 HU时敏感度69%、特异度95%。
  • 虚拟平扫CT肝衰减较真平扫CT平均高6.8±6.9 HU,两者强相关(r=0.81,p<0.001)。

核心结论

  • 虚拟平扫CT肝衰减检测至少中度肝脂肪变性有较好应用前景,提出的46 HU阈值提供高特异度和中等敏感度。

研究设计与样本

  • 单机构回顾性研究,训练队列236例,验证队列80例,采用多期相双源双能量CT,以真平扫肝脏衰减<40 HU为至少中度肝脂肪变性的参考标准。

关键影像表现/征象

  • 真平扫与虚拟平扫平均肝衰减分别为51.3±10.8 HU和58.1±11.5 HU(p<0.001),平均差值(虚拟平扫减真平扫)为6.8±6.9 HU。
  • 真平扫与虚拟平扫肝衰减强相关(r=0.81,p<0.001)。

诊断标准与关键数值

  • 真平扫肝脏衰减<40 HU定义为至少中度肝脂肪变性。
  • 虚拟平扫肝衰减检测肝脂肪变性AUC:全肝0.92(95%CI 0.86-0.98)、左外侧段0.92(95%CI 0.87-0.97)、左内侧段0.92(95%CI 0.86-0.99)、右前段0.91(95%CI 0.84-0.97)、右后段0.87(95%CI 0.80-0.95)。
  • 阈值40 HU时虚拟平扫敏感度100%、特异度42%;优化阈值46 HU时敏感度69%、特异度95%。
  • 优化阈值46 HU在验证队列(n=80)中表现相似。

临床应用与阅片要点

  • 虚拟平扫CT肝衰减可用于检测至少中度肝脂肪变性,46 HU阈值提供高特异度和中等敏感度。
  • 虚拟平扫肝衰减较真平扫平均高6.8±6.9 HU,阅片时需注意两者数值差异。

局限性

  • 本研究为单机构回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate diagnostic accuracy of virtual non contrast (VNC) images, based on dual-source dual-energy CT (dsDECT), for detection of at least moderate steatosis and to define a threshold value to make this diagnosis on VNC.

METHODS: This single-institution retrospective study included patients who had multi-phasic protocol dsDECT. Regions of interests were placed in different segments of the liver and spleen on true non-contrast (TNC), VNC, and portal-venous phase (PVP) images. At least moderate steatosis was defined as liver attenuation (LHU) < 40 HU on TNC. Diagnostic performance of VNC to detect steatosis was determined and the new threshold was tested in a validation cohort.

RESULTS: 236 patients were included in training cohort. Mean liver attenuation values were 51.3 ± 10.8 HU and 58.1 ± 11.5 HU for TNC and VNC (p < 0.001), with a mean difference (VNC - TNC) of 6.8 ± 6.9 HU. Correlation between TNC and VNC was strong (r = 0.81, p < 0.001). The AUCs of LHU on VNC for detection of hepatic steatosis were 0.92 (95 % Cl: 0.86-0.98), 0.92 (95 % Cl: 0.87-0.97), 0.92 (95 % Cl: 0.86-0.99), 0.91 (95 % Cl: 0.84-0.97), and 0.87 (95 % Cl: 0.80-0.95) for entire liver, left lateral, left medial, right anterior, and right posterior segments, respectively. VNC had sensitivity/specificity of 100 % /42 % when using a threshold of 40 HU; they were 69 % and 95 %, respectively, when using optimized threshold of 46 HU. This threshold showed similar performance in validation cohort (n = 80).

CONCLUSIONS: Hepatic attenuation on VNC has promising performance for detection of at least moderate steatosis. Proposed threshold of 46 HU provides high specificity and moderate sensitivity to detect steatosis.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Catania R, Jia L, Haghshomar M, et al. Detection of moderate hepatic steatosis on contrast-enhanced dual-source dual-energy CT: Role and accuracy of virtual non-contrast CT. Eur J Radiol. 2024. PMID: 38325187. doi:10.1016/j.ejrad.2024.111328

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。